Home » Authors » Anette Breindl

Articles by Anette Breindl

New Contributor To Depression's Genetic Basis: SSRI Sensitivity

Dec. 20, 2004

By Anette Breindl

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

For Once, Selective Pressure Leads To Nonfunctional Gene

Dec. 3, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...